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A B S T R A C T
In this retrospective study we have analysed 10-year period results of all type periprosthetic hip joint infection treat-
ments at our Department. Data for 73 patients were analysed and functional status for 41 patients evaluated. A smaller
proportion of patients (45%) with resection arthroplasty as the definitive solution were satisfied. These were mostly fe-
males with numerous comorbidities and lower functional demands. Much better results were achieved in 2-stage revi-
sion arthroplasty group. In conclusion whenever possible revision arthroplasty should be done because probability of
re-infection is much lower than was previously believed, and the functional status of patients and their general life satis-
faction is much higher.
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Introduction
Periprosthetic hip joint infection occurs in 1–2% of
joint replacements, and is one of the leading causes of
arthroplasty failure1–3. Treatment includes one or two-
-stage replacement arthroplasty followed by antibiotic
therapy4,5. Resection arthroplasty was once a definitive
solution for septic or aseptic hip endoprosthesis loosen-
ing treatment6,7. Today it is mainly used as the first step
in two-step revision arthroplasty; which is associated
with the highest success rates in treatment of peripro-
sthetic hip infections8. Rarely, in immune-compromised,
older patients with poor general health or with highly re-
sistant strains infection, resection arthroplasty is used as
definitive solution. Advantage of resection arthroplasty
is in a lower risk of recurrent infection compared to other
treatment methods6,9. But problems related to this kind
of treatment are inferior functional results, with abduc-
tor weakness related limping, significant leg abbrevia-
tion, instability, walking difficulties that require more
energy, increased stress on lumbar spine and other
joints9. On the other hand, late revision arthroplasty car-
ries certain risks, such as re-infection, abductor muscles
weakness, hip joint dislocation, limping and limited func-
tion improvement10.
In our department periprosthetic hip joint infection
treatment includes antibiotic therapy with two-stage re-
vision. Hip endoprosthesis removal is the first step in po-
tential two-stage revision, but in cases where the treating
surgeon or the patient decided against revision arthro-
plasty, resection arthroplasty was the final treatment.
Such a decision is made when the infection is caused by
highly resistant pathogens, in cases of positive control
punctures, positive scintigraphy scan findings, and in pa-
tients who have very poor general health state with nu-
merous comorbidities, where a new surgical procedure
would represent additional and unnecessary risk.
The aim of our paper is to analyse 10-year period re-
sults of all type of treatments at our Department. Out-
come and functional status of patients after revision hip
arthroplasty and resection arthroplasty as definitive pro-
cedure was measured and analysed.
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Material and Methods
In this retrospective, by Hospital Ethical Review
Committee approved study we have analysed data of pa-
tients treated for septic hip loosening during ten years
period (between 2000 and 2009). In that time period, 78
patients were treated with resection arthroplasty as the
first step in possible two-stage revision. Out of these,
medical documentation for 5 patients was lost, while the
documentation for 73 patients was available for analysis.
In the meantime, ten patients died. We have analysed
medical documentation of all 73 patients and addition-
ally 41 of 63 patients were clinically examined at final fol-
low up visits. Patients who were not included in the final
clinical examination (N=22) were either lost for follow
up or refused to participate. For these patients functional
scores were all marked as poor results (Figure 1). All pa-
tients signed the Informed consent form prior to any
study procedure. Analysed patients data were divided in
two groups. The first group included patients with resec-
tion arthroplasty as the first step in two-step revision,
and second group of patients were those with resection
arthroplasty as final treatment.
The analysis of patient data included following: type
and duration of symptoms before resection arthroplasty,
the indications for surgical treatment, preoperative hip
aspirations, the presence of the fistulas, preoperative and
intraoperative cultures, laboratory and scintigraphy
scan findings, presence of comorbidity and duration of
antibiotic therapy. This was followed by analysis of func-
tional status of 41 patients who agreed to participate.
Functional results of patients with revision arthro-
plasty were compared to results of patients with resec-
tion arthroplasty. The same independent examiner clini-
cally examined patients. For functional assessment follo-
wing questionnaires were used: Harris hip score (HHS)11
a system filled out by the physician for rating hip func-
tion, and four questionnaires filled out by the patient
measuring several functionalities and change in health
status: Short Form Health Survey (SF 36)12,13, Dart-
mouth Primary Care Cooperative Research Network
(COOP) and the World Organization of National Col-
leges, Academies, and Academic Associations of General
Practitioners/Family Physicians (WONCA) score (COOP/
WONCA)14, Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC)15, Falls Efficacy Scale-
-International (FES-I)16.
Results
The first group included 20 patients with hip revision
arthroplasty after resection arthroplasty. Three patients
died in the meantime, one due to prostate cancer, and
two due to a heart disease. The average age was 62.45
years (range 45–77 years). There were 9 female and 11
male patients. The second group consisting of 53 patients
for whom it was decided (for various reasons) to be
treated only by resection arthroplasty as final treatment.
Average age in this group was 65.32 years (range 35–87
years) and there were 20 male and 33 female. Almost all
patients had associated comorbidities, most commonly
hypertension, cardiomyopathy and diabetes, also gout,
rheumatoid arthritis, ankylosing spondylitis. Seven pa-
tients died in the mean time. The remaining patients in
this group were divided into two subgroups. One sub-
group included 24 patients relatively satisfied with re-
sults of this kind of treatment. One of these patients had
bilateral resection arthroplasty. Second subgroup inclu-
ded 22 patients who were dissatisfied with the resection
arthroplasty; 4 of them underwent revision arthroplasty
in other institutions, 4 live abroad, and 14 are very un-
happy with the treatment results and did not want to
participate in this study. All of them we marked as poor
results.
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Fig. 1. Patient distribution.
Analysis of gathered data (Table 1) showed that time
since primary hip arthroplasty to hip resection arthro-
plasty was on average 88 months, or 7.3 years (from 4
months to 29 years). Discomfort, primarily pain and
limping, on average, lasted 25 months (1 month to 10
years) before resection arthroplasty was done. Some pa-
tients have had swelling and redness locally, and in 22
cases fistulas were present. In most patients, we found
increased levels of inflammatory parameters (erythro-
cyte sedimentation rate – ESR and C-reactive protein).
The average value of the erythrocyte sedimentation rate
was 49.96 (5 to 145) and C-reactive protein 44.95 (4 to
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TABLE 1
COMPARISON OF MEDICAL DOCUMENTATION DATA AND FUNCTIONAL RESULTS AFTER RESECTION ARTHROPLASTY
AND HIP REVISION ARTHROPLASTY
Revision
arthroplasty
Resection arthroplasty
as definitive solution
p
Medical documentation data comparition
Average age/years±SD (min-max) 62.45±9.17 (41–77) 66.58±10.25 (35–88) p=0.12
Male 11 (20) 20 (53) p=0.18
Female 9 (20) 33 (53)
Positive Technetium scintigraphy 16/20 31/53 p=0.087
Positive Gallium Scintigraphy 13/20 30/53 p=0.52
Average ESR±SD (min-max) 43.65±22.66 (2–85) 57.36±33.25 (5–140) p=0.094
Average CRP±SD (min-max) 37.75±34.48 (3–145) 54.76±61.48 (4–353) p=0.29
Positive preoperative culture 4 (20) 21/53 p=0.115
Positive intraoperative culture 12 (20) 41/53 p=0.138
Antibiotic therapy duration±SD (min-max) 39.25 47.54 p=0.36
Average time from endoprothesis extraction to
rearthroplasty±SD (min-max)
14.05±7.45 (3–36) –
Luxation after rearthroplasty 3 (20) –
Reinfection after rearthroplasty 0
Average range of motion
Average flexion±SD (min-max) 86.82°±9.55° (70°–100°) 84.8°±13.88° (50°–100°) p=0.66
Average extension±SD (min-max) –0.91°±3.02° (–10°–0°) 0°±0° p=0.13
Average abduction±SD (min-max) 32.27°±6.46° (25°–45°) 35.6°±9.35° (25°–50°) p=0.29
Average adduction±SD (min-max) 20.91°±8.01° (10°–30°) 22°±10.10° (10°–40°) p=0.75
Average internal rotation±SD (min-max) 6.82°±4.05° (0°–10°) 17.60°±10.42° (0°–40°) *p=0.002
Average external rotation±SD (min-max) 18.18°±11.68° (5°–40°) 26.20°±10.03° (10°–45°) *p=0.043
Positive Trendelenburg sign 9 (17) 23 (24) *p=0.001
Average leg abbreviation/cm±SD (min-max) 1.64±0.83 (0–3) 5.52±2.77 (0–11) *p=0.00007
Walking aid using
no aid 10 (17) 0 (24) *p=0.000001
one cruch 5 (17) 7 (24)
two cruches 2 (17) 13 (24)
walker 0 (17) 4 (24)
Scores
VAS 1.4 2.80 p=0.168
COOP WONCA 19.20 22.4 p=0.13
SF 36 PCS 36.5 27.7 *p=0.024
SF 36 MCS 48.5 45.5 p=0.8
SES 16.90 27.0 *p=0.0067
HARRIS HIP 77.4 52.2 *p=0.00001
WOMAC 26.0 47.2 *p=0.012
*p>0.001, **p>0.05, ESR – erythrocyte sedimentation rate, CRP – C-reactive protein, VAS – visual analogue scale, COOP/WONCA
Dartmouth Primary Care Cooperative Research Network and the World Organization of National Colleges, Academies, and Academic
Associations of General Practitioners/Family Physicians score, SF 36 – Short Form 36, PSC – Physical Component Summary, MSC –
Mental Component Summary, WOMAC – Western Ontario and McMaster Universities Osteoarthritis Index
353). Also, suspicion of infection was confirmed with pos-
itive scintigraphy findings with technetium, gallium or
both. Most common intraoperativelly isolated pathogens
were: Staphylococcus epidermidis, Staphylococcus au-
reus and Coagulase negative Staphylococcus (Table 2).
All patients underwent antibiotic therapy after surgical
treatment according to the antibiogram with average du-
ration of 43.39 days (10–300 days). Average time from
Girdlestone procedure to revision arthroplasty as second
stage was 14.05 months (from 3 months to 3 years). After
revision arthroplasty there were no re-infections. In one
case re-acetabuloplasty was subsequently performed be-
cause of aseptic instability. Three patients had one dislo-
cation after revision arthroplasty, and one of them
needed an open reduction. Amount of pain did not differ
between groups on final examination. Patients in both
groups had similar postoperative range of motion except
for internal and external hip rotation which was signifi-
cantly better in resection arthroplasty group. Walking
aids were significantly less used in revision arthroplasty
group (p<0.001) and less fear of fall was recorded with
FES questionnaire (p=0.0067). Patients in revision
arthroplasty had higher score of physical component of
SF 36 (p=0.024), while mental SF36 and COOPWONCA
evaluation showed no differences between groups. Hip
specific questionnaires showed significantly better re-
sults for patients in revision arthroplasty group both for
HHS (p<0.001) and WOMAC score (p=0.12, Table 1).
Discussion and Conclusion
Treatment of prosthetic hip joint infections involves
surgery and antibiotic therapy4. The type of surgery and
antibiotic therapy depends on the timeframe of infection,
type of microorganism and other individual patient’s cir-
cumstances. At our department we perform two-stage re-
vision arthroplasty whenever possible. We usually im-
plant cementless total hip endoprosthesis with manda-
tory antibiotic prophylaxis, which is continued until final
results of intraoperative cultures arrive. Then the ther-
apy is discontinued if the cultures are negative or contin-
ued if the cultures are positive. Some authors suggested
that 12 months is the optimal interval between endopro-
sthesis removal and revision arthroplasty, however it re-
mains unclear on what basis this conclusion was made17.
In our study interval between endoprosthesis removal
and revision arthroplasty was on average 14.05 months
(from 3 months to 3 years). In cases with longer time in-
terval it was mostly due to fear of re-infection, which is
often mentioned in the literature11. Lange et al.18 ana-
lysed 36 studies that included patients with an infection
of a total hip endoprothesis treated with either one-stage
or two-stage revision arthroplasty and found out that re-
infection occurred with an estimated absolute risk of
13.1% in the one-stage revision and 10.4% in the two-
-stage revision. In our study we had no re-infections after
revision arthroplasty. Revision arthroplasty after resec-
tion arthroplasty is a complex procedure, but it can offer
increase in function and decrease of pain for these pa-
tients. There was a significant increase in stability, a sig-
nificant decrease in leg length difference (which in our
patients decreased from an average of 6.8 cm to 1.6 cm)
without any neurological disturbances (Table 1). Pa-
tients for whom revision arthroplasty was done, were
satisfied with the result of treatment, had no significant
problems and functional results were satisfactory. There
was decreased fear of falling, however four patients used
one or two crutches, not because they really need them,
but because of sense of greater stability. In cases of poor
general condition, many comorbidities and positive con-
trol laboratory findings we decided against revision art-
hroplasty but for resection arthroplasty as a final treat-
ment. Oheim et al.19, state that resection arthroplasty is
still essential surgical strategy for treating hip joint
empyema in cases in which functional outcome is of minor
priority. Many authors agree that resection arthroplasty
is a successful method of eradication of infection17,20–22.
There are data confirming that 97.7% patients with re-
section arthroplasty are free of infection23. But most au-
thors agree that these patients have poor functional
status21,24. Similar findings were shown in our results in
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TABLE 2
INTRAOPERATIVE CULTURE FINDINGS AND ANTIBIOTICS THERAPY DURATION
Intraoperative culture
Resection arthroplasty
as final solution
Revision
arthroplasty
Average antibiotic therapy
duration / days
Sterile 11 (53) 8 (20) 20.68
Streptococcus epidermidis 12 (53) 4 (20) 45.45
Staphylococcus aureus 5 (53) 2 (20) 55.75
MRSA 7 (53) 0 (20) 52.50
Coagulase negative Staphylococcus 6 (53) 2 (20) 46.28
Pseudomonas aeruginosa 1 (53) 1 (20) 52.50
Enterococcus faecalis 0 (53) 1 (20) 70
Acinetobacter spp 1 (53) 0 (20) 45
Salmonella 1 (53) 0 (20) 30
Corynebacterium spp 1 (53) 0 (20) 90
Mixed infection 7 (53) 2 (20) 76
patients with resection arthroplasty as definitive solu-
tion. Patients have good range of hip motion, with a sig-
nificant reduction in pain, but there is increased sense of
instability with a positive Trendelenburg sign. Also, leg
length discrepancy of on average 6 cm (range from 3 to
11 cm) is troublesome. More than half of the patients in
this group (14 patients; 58%) wear orthopaedic shoes
with a corresponding rise of the heel, and all are perma-
nently dependent on some kind of orthopaedic aids to
help them walking, mostly in the form of two forearm
crutches, walkers, or rarely one crutch. A smaller propor-
tion of patients (24 patients; 45%) with resection arthro-
plasty as the final treatment were satisfied with this
method of treatment7 primarily because of the fact that
the infection was cured. These are mostly frail females,
with numerous comorbidities and low functional de-
mands. They have a significant reduction in pain with a
relatively satisfactory function, but because of fear of
re-infection, they would hardly decide for revision ar-
throplasty. Twenty-two patients (42%) were extremely
unhappy with the results of resection arthroplasty and
did not want to participate in the study. Although we
could not analyse their functional status but by phone in-
terview, we found out that their dissatisfaction was pri-
marily due to sense of instability in operated hip, signifi-
cant leg abbreviation and the need for mandatory use of
at least one crutch, resulting with significant influence
on daily activities.
In conclusion we think that resection arthroplasty is
still a viable option to save irretrievably failed hips in
medically compromised patients. Limb shortening and
inevitable need for walking aids should be clearly ex-
plained to patients during the consenting process in or-
der to avoid unrealistic expectations. We believe that
whenever the general health status of the patient and
the successful eradication of pathogens allow it, revision
arthroplasty should be done. With a well-preformed sur-
gical treatment, adequate and long enough antibiotic
therapy and appropriate antibiotic prophylaxis during
revision arthroplasty, the probability of reinfection is
much lower than was previously believed, and the func-
tional status of patients and their general life satisfac-
tion is higher.
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ZADOVOLJSTVO BOLESNIKA NAKON REARTROPLASTIKE TE RESEKCIJSKE
ARTROPLASTIKE U LIJE^ENJU PERIPROTETI^KE INFEKCIJE KUKA
S A @ E T A K
U ovoj retrospektivnoj studiji su analizirani rezultati lije~enja periproteti~ke infekcije kuka u vremenskom periodu
od deset godina. Analizirani su podaci iz medicinske literature 73 bolesnika, a u 41 bolesnika u~injena je i analiza
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funkcionalnog statusa. Manji broj bolesnika s resekcijskom artroplastikom kao definitivnim rje{enjem je zadovoljan
rezultatima lije~enja. To su uglavnom `ene starije `ivotne dobi s brojnim komorbiditetima i ni`im funkcionalnim zah-
tjevima. Mnogo bolji rezultati su dobiveni u skupini bolesnika kojima je naknadno u~injena revizijska artroplastika
kuka. Temeljem dobivenih rezultata zaklju~ujemo kako bi kada god je to mogu}e trebalo u~initi revizijsku artroplastiku
kuka, jer je vjerojatnost reinfekcije zna~ajno manja nego {to se ranije mislilo, a funkcionalni status bolesnika i njihovo
op}e zadovoljstvo `ivotom puno ve}e.
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